BIOPHYTIS
Biophytis is a clinical-stage biotechnology company focused on the development of therapeutics that slow the degenerative processes associated with aging and improve functional outcomes for patients suffering from age-related diseases. Their goal is to become a leader in the emerging field of aging science by delivering life-changing therapies to the growing number of patients in need that have limited or no treatment options. To accomplish this goal, they have assembled an experienced and skilled group of industry professionals, scientists, clinicians and key opinion leaders from leading industry and academic institutions from around the world.
BIOPHYTIS
Industry:
Biotechnology Nutraceutical Pharmaceutical
Founded:
2006-01-01
Address:
Paris, Ile-de-France, France
Country:
France
Website Url:
http://www.biophytis.com
Total Employee:
11+
Status:
Active
Contact:
+33 1 44 27 23 00
Total Funding:
34.34 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
PIQUR Therapeutics
PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.
Reata Pharmaceuticals
Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.
Current Employees Featured
Founder
Stock Details
Investors List
Kreos Capital
Kreos Capital investment in Post-IPO Debt - Biophytis
Atlas Capital Markets
Atlas Capital Markets investment in Post-IPO Equity - Biophytis
Bpifrance
Bpifrance investment in Post-IPO Debt - Biophytis
Bpifrance
Bpifrance investment in Grant - Biophytis
Metabrain Research SAS
Metabrain Research SAS investment in Series B - Biophytis
CM-CIC Capital Prive
CM-CIC Capital Prive investment in Series B - Biophytis
Seventure Partners
Seventure Partners investment in Series B - Biophytis
AGORANOV
AGORANOV investment in Venture Round - Biophytis
Key Employee Changes
| Date | New article |
|---|---|
| 2022-04-05 | Biophytis appoints Philippe Rousseau as Chief Financial Officer |
Official Site Inspections
http://www.biophytis.com
- Host name: 151-236-54-229.static.as29550.net
- IP address: 151.236.54.229
- Location: United Kingdom
- Latitude: 51.4964
- Longitude: -0.1224
- Timezone: Europe/London
More informations about "Biophytis"
Corporate - Biophytis
Biophytis is a clinical-stage biotechnology company specialized in the development of therapeutics that are aimed at slowing the degenerative processes associated with aging and …See details»
Biophytis - Crunchbase Company Profile & Funding
Biophytis announced its 2023 financial results and provided an update on its business activities. The company also launched a trial targeting muscle loss in GLP-1 obesity treatment. …See details»
Biophytis Company Profile | Management and Employees List
Biophytis Profile and History. Founded in 2006, Biophytis SA is a clinical-stage biotechnology company specialized in the development of therapeutics that are aimed at slowing the …See details»
BIOPHYTIS - Live Healthier Longer - LinkedIn
Biophytis SA is a clinical-stage biotechnology company specialized in the development of therapeutics that are aimed at slowing the degenerative processes associated with aging.See details»
Biophytis - Overview, News & Similar companies | ZoomInfo.com
Apr 17, 2023 Who is Biophytis. Founded in 2006, Biophytis SA is a clinical-stage biotechnology company specialized in the development of therapeutics that are aimed at slowing th e …See details»
Corporate Presentation - Biophytis
Download the latest corporate presentation of Biophytis and get the latest information on ongoing studies.See details»
Biophytis Company Profile - Office Locations, Competitors, …
Sep 25, 2024 Biophytis (formerly known as Institut Biophytis) is a biotechnology company focused on the development of drug candidates for the treatment of age-related diseases. It …See details»
Biophytis - Org Chart, Teams, Culture & Jobs - The Org
View Biophytis' up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
Biophytis - Funding, Financials, Valuation & Investors - Crunchbase
Biophytis is registered under the ticker NASDAQ:BPTS . Their stock opened with $16.75 in its Feb 10, 2021 IPO. Stock Symbol NASDAQ:BPTS ; Valuation at IPO $1.9B; Money Raised at IPO …See details»
Biophytis - VentureRadar
" Biophytis is a clinical-stage biotechnology company focused on the development of therapeutics that slow the degenerative processes associated with aging and improve functional outcomes …See details»
Biophytis - Contacts, Employees, Board Members, Advisors & Alumni
Biophytis is a research company that focuses on the fields of metabolic and age-related diseases.See details»
Biophytis Announces the Design of its Phase 2 OBA Clinical Study …
PARIS, FRANCE and CAMBRIDGE, MA / ACCESSWIRE / May 14, 2024 / Biophytis SA (Euronext Growth Paris:ALBPS), ("Biophytis" or the "Company"), a clinical-stage …See details»
Biophytis
Biophytis accorde à Blanver les droits exclusifs de BIO101 en Amérique Latine dans un accord pouvant atteindre 108 M€ Biophytis annonce la signature d’un accord de licence exclusive …See details»
Biophytis Strengthens its Management Team with the …
Sep 14, 2023 Biophytis SA (Nasdaq CM:BPTS, Euronext Growth Paris:ALBPS), (Biophytis), a clinical-stage biotechnology company specialized in the development of therapeutics that are …See details»
Delving into the Latest Updates on Biophytis SA with Synapse
Stanislas Veillet, CEO of Biophytis, stated: "The Covid pandemic is far from over: according to the World Health Organization, 134,797 new cases of Covid-19 and 1,691 deaths have been …See details»
Our Science - Biophytis
We specialize in the development of therapeutics that are aimed at slowing the degenerative processes associated with aging and improving functional outcomes for patients suffering from …See details»
BIOPHYTIS Cours Action ALBPS, Cotation Bourse Euronext Paris
Le cours de l'action BIOPHYTIS ALBPS en temps réel sur Boursorama : historique de la cotation sur Euronext Paris, graphique, actualités, consensus des analystes et informations boursièresSee details»
Pipeline - Biophytis
PIPELINE SARCOPENIA (SARA CLINICAL PROGRAM) Sarcopenia is an age-related degeneration of skeletal muscle characterized by a loss of muscle mass strength, balance and …See details»
Biophytis Reports 2020 Full Year Results
On Biophytis's website: www.biophytis.com) Launch of the Phase 2-3 COVA study in patients with severe respiratory manifestation of COVID-19 • In May 2020, Biophytis received approval from …See details»